FutureChem Co., Ltd.
Develops radiopharmaceuticals and synthesis equipment for diagnostics and therapy.
220100 | KO
Overview
Corporate Details
- ISIN(s):
- KR7220100002
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 성동구 성수일로8길 59 평화빌딩 B동 3층(성수동2가), 서울특별시
- Sector:
- Manufacturing
Description
FutureChem Co., Ltd. is a company specializing in the development and production of radiopharmaceuticals for diagnostic and therapeutic applications. The company's operations cover the manufacturing of radiopharmaceutical precursors, chemical compounds, synthesis reagents, and automated synthesis modules. Its product pipeline focuses on agents for the diagnosis and treatment of various cancers and neurological disorders, including Parkinson's disease. FutureChem supports the broader radiopharmaceutical field by providing both finished products and the essential chemical building blocks and equipment required for their synthesis. The company actively establishes global partnerships for clinical supply and commercial licensing of its technologies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-15 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 916.2 KB | ||
| 2022-03-11 00:00 |
주주총회소집결의
|
Korean | 15.0 KB | ||
| 2022-03-11 00:00 |
주주총회소집공고
|
Korean | 150.3 KB | ||
| 2022-03-11 00:00 |
의결권대리행사권유참고서류
|
Korean | 908.3 KB | ||
| 2022-02-11 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 12.3 KB | ||
| 2022-02-08 00:00 |
투자판단관련주요경영사항(전이성 거세저항성 전립선암 환자에 대한 [177Lu]루도타다이펩의 반복투여 치료의 안전성 및 유효성 평가; 제2상 임상…
|
Korean | 10.7 KB | ||
| 2022-02-07 00:00 |
투자판단관련주요경영사항(생화학적 재발 전립선암(BRPC) 환자에서의 [18F]Florastamin PET/CT 영상검사의 진단 유효성 및 안전…
|
Korean | 12.4 KB | ||
| 2022-02-03 00:00 |
투자판단관련주요경영사항(전립선암 진단용 방사성의약품 미국임상 1상 종료)
|
Korean | 8.8 KB | ||
| 2021-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-11-24 00:00 |
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2021-11-15 00:00 |
분기보고서 (2021.09)
|
Korean | 1.5 MB | ||
| 2021-10-14 00:00 |
기타경영사항(특허권취득)(자율공시)(전립선암 진단 및 치료를 위한 PSMA-표적 방사성의약품(PSMA-targeting radiopharmac…
|
Korean | 7.5 KB | ||
| 2021-09-16 00:00 |
기타경영사항(특허권취득)(자율공시)(전립선암 진단 및 치료를 위한 PSMA-표적 방사성의약품)
|
Korean | 7.2 KB | ||
| 2021-08-17 00:00 |
반기보고서 (2021.06)
|
Korean | 1.5 MB | ||
| 2021-07-23 00:00 |
기타경영사항(특허권취득)(자율공시)(새로운 18F-표지된 친디엔체와 테트라진 화합물과의 IeDDA 반응을 이용한 18F-표지 방법)
|
Korean | 6.3 KB |
Automate Your Workflow. Get a real-time feed of all FutureChem Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for FutureChem Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for FutureChem Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
